Company Profile
Cogent Biosciences Stock Price, News & Analysis
- Ticker:
- COGT
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Cogent Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
36.31 USD (+1.31%)
Close
Last updated: June 23, 2026 at 00:00
6.2B USD
Market cap
Why the stock is moving
COGT is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Cogent Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Cogent Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Cogent Biosciences follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Cogent Biosciences sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
- 04
- 05
Cogent Biosciences Announces Participation in the 2026 Jefferies Global Healthcare Conference
Source: Cogent Biosciences
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Cogent Biosciences (COGT)?
Cogent Biosciences (COGT) most recently closed at 36.31 USD, a +1.31% move versus the previous session.
What is the market cap of Cogent Biosciences (COGT)?
Cogent Biosciences currently has a market capitalization of 6.2B USD on BioPharmSignal.
What does Cogent Biosciences do?
Cogent Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is COGT stock listed?
Cogent Biosciences (COGT) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Cogent Biosciences is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Cogent?
Cogent Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Cogent Biosciences targeting with Cogent?
Cogent Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Biosciences?
Cogent Biosciences is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.